Skip to main content
. 2009 Feb 3;100(5):817–821. doi: 10.1038/sj.bjc.6604906

Table 1. Characteristics of breast cancer cases (overall and by ER status) and controls.

  Controls (N=84 778) All cases (N=84 778) ER-positive casesa (N=56 296) ER-negative casesa (N=9991)
  %
Age in years (median) (76.0) (76.0) (76.0) (75.0)
 67–70 19.2 19.1 19.2 21.3
 71–75 28.0 28.3 28.6 29.4
 76–80 24.9 25.3 25.8 24.4
 81–84 14.6 13.9 16.4 15.2
 85+ 13.3 13.3 10.1 9.7
         
Race        
 White 83.7 88.5 89.8 84.7
 Black 7.7 6.4 5.2 9.4
 Hispanic 2.4 1.3 1.2 1.5
 Others/unknown 6.2 3.8 3.8 4.4
         
Region of residence b
 Western 51.2 51.3 52.8 47.9
 Northeastern 17.0 17.6 16.6 18.8
 North-central 20.1 20.1 20.0 21.1
 Southern 11.7 11.0 10.6 12.2
         
Income c        
 <$25 000 20.8 18.7 18.3 20.2
 $25 000–$34 999 28.1 28.1 28.5 28.2
 $35 000–$49 999 32.4 33.0 33.0 32.4
 ⩾$50 000 13.2 14.0 14.2 13.4
 Unknown 5.4 6.2 6.0 5.8
         
Selection year        
 1993–1995 22.5 22.5 21.1 23.3
 1996–1999 31.5 31.5 31.9 32.5
 2000–2002 46.0 46.0 47.0 44.2
         
Mammography d        
 Yes 45.4 50.5 52.0 48.7
 No 54.6 49.5 48.0 51.3
         
Months of coveragee (median) (102.0) (101.0) (102.0) (98.0)
 12–23 3.2 3.2 3.3 3.1
 24–59 19.2 19.2 19.3 21.1
 60+ 77.6 77.6 77.4 75.8
         
Number of physician visitsf (median) (11.0) (12.0) (12.0) (12.0)
 0 16.0 15.3 15.2 15.2
 1–11 36.7 35.2 35.3 36.8
 12–23 23.2 24.4 24.7 23.4
 24+ 24.1 25.1 24.8 24.6
a

ER status is missing for 18 491 breast cancer cases

b

Western region includes Hawaii, New Mexico, San Francisco, Seattle, Utah, San Jose, Los Angeles, and Greater California; North eastern region includes Connecticut and New Jersey; North-central includes Detroit and Iowa; Southern region includes Atlanta, rural Georgia, Kentucky, and Louisiana.

c

Median household income by residential zip code.

d

Ever had mammography 12–48 months before case–control selection.

e

Number of months of total simultaneous coverage part A, B, and non-HMO.

f

Number of visits to a physician 12–24 months before case–control selection.